Cause IQ organization profile

Sabin Vaccine Institute

Program areas | Form 990s | Financials | Vendors | Personnel | Peers

Sabin Vaccine Institute is a international development organization based in Washington, DC that was founded in 1994. As of 2020 they had $9.5 million in revenue and $12 million in assets.

Sabin Vaccine Institute (Sabin) is a non-profit, 501(c)(3) organization made up of scientists, researchers, and advocates dedicated to reducing needless human suffering from vaccine preventable and neglected tropical diseases.

Previous legal names or variations of their name include: Albert B Sabin Vaccine Institute.

(202) 842-5025
Fiscal year end:
Revenue trends:
Asset trends:

Program areas at Sabin Vaccine Institute

Vaccine Access and Uptake:Despite scientific advances and international support, 1.5 million people still die each year from diseases that could have been prevented by routine immunization. Sabin works with key decision makers and immunization experts at the country and global level to build resilient, sustainable national immunization programs to reach every child.Sabin is an adviser, a convener and a catalyst of systemic change, bringing together researchers, national government officials and immunization specialists at all levels to support the introduction and expansion of new and under-utilized vaccines. In order to make informed decisions about vaccine introduction and implementation, countries require high-quality information and evidence. Sabin supports surveillance programs and conducts research to generate essential epidemiological data for well-designed and efficiently implemented immunization programs. By establishing and sharing best practices, we help countries evaluate and streamline vaccine introduction and scale-up.Collaboration across continents and sectors is critical to extend the benefits of immunization ...

Vaccine Research and Development:The Sabin Vaccine Institute supports innovative technologies and approaches in vaccine research and development to combat infectious and emerging threats to global health. Sabin's R&D strategy is to advance the development of vaccine candidates that have demonstrated early scientific value but have little commercial value, targeting diseases that impact the world's most vulnerable populations. Sabin leverages the expertise of partners in the academic, public and private sectors, and promotes open-source research.Ebola has taken the lives of more than 13,000 people in recent years. To protect communities across the globe from the critical threat posed by Ebola and the closely related, but lesser known, Marburg virus, Sabin is developing vaccines based on technology for three clinical-stage candidate vaccines licensed from GSK. The agreement involves prophylactic candidate vaccines to protect against Ebola Zaire, Ebola Sudan and Marburg virus, all based on GSK's proprietary ChAd3 platform. In an additional agreement, ...

Vaccine Knowledge and Innovation:The immunization landscape is constantly evolving. Immunization professionals are faced with the challenge of staying up-to-date on new vaccines, changing policies and recommendations, and developments in vaccine science, while the general public is inundated with information, making it difficult to discern truth from fiction.Sabin drives meaningful, well-informed conversations on emerging and established issues across the field of immunization and provides training and education on the latest in vaccine science and policy to immunization professionals, policymakers and journalists, among others.Sabin fosters a global community that enables immunization professionals to connect with peers and experts, learn skills that build capacity and advance careers, and lead immunization programs in challenging contexts.Sabin works to shape the vaccine conversation by amplifying reliable information on vaccines. We work to dispel misinformation, understand the social drivers of vaccination decisions through research, and understand the role of social media on vaccine confidence. We serve as ...

Form 990s for Sabin Vaccine Institute

Fiscal year endingDate received by IRSFormPDF link
2018-12Oct 25, 2019990View PDF
2017-12Nov 15, 2018990View PDF
2016-12Oct 16, 2017990View PDF
2015-12Jan 5, 2017990View PDF
2014-12Jul 13, 2015990View PDF
...and five more Form 990 PDFs

Financials for Sabin Vaccine Institute

Total grants, contributions, etc.$9,462,400
Program services$0
Investment income and dividends$68,713
Tax-exempt bond proceeds$0
Royalty revenue$0
Net rental income$0
Net gain from sale of non-inventory assets$0
Net income from fundraising events$0
Net income from gaming activities$0
Net income from sales of inventory$0
Miscellaneous revenues$17,077
Total revenues$9,548,190

Vendors for Sabin Vaccine Institute

VendorServicesAmount paidDate
Rogers and Company PLLCTax accounting2020-08-07
██████Content management system software2020-02-29
████████ ████████Fundraising software; Advocacy software2020-02-29
███ ███ ███Support R D Qa PM Govt Compliance$495,2652019-12-01
███████ ██████████ ██ ███Platform Development for Boost Program$542,4422019-12-01
███ ██████ ██████████ █████ ███Review Business Plan for Flu Program$399,0722019-12-01
███ █████ █████████Convene Stakeholders for Vad Program$299,2472019-12-01
████ ██████Branding and Promotions Flu Program$343,1172019-12-01
...and one more vendors

Personnel at Sabin Vaccine Institute

NameTitleCompensationMost recent data
Amy FinanChief Executive Officer$230,556Oct. 25, 2019
Davis BrianOfficer - Chief Operating Officer$240,580Dec. 31, 2018
████ ████ ██████Vice President, Communications-July 17, 2019
████ ███████Vice President of Resource Development and Policy$130,921July 17, 2019
██████ ███████Vice President, Typhoid Programs$190,604July 17, 2019
███████ ██████Vice President , Typhoid Program$216,067Dec. 31, 2018
███████ █████Director , Administration$113,250Dec. 31, 2018
███████ █████Director , Accounting$129,125Dec. 31, 2018
█████ ███████Director of Accounting-July 17, 2019
█████ ███████Director, Administrationjanet Daniels, MBA Director, Accounting-July 17, 2019
...and 21 more key personnel

Peer international development and relief organizations

1Center for International Private Enterprise501(c)(3)$26 millionWashington, DC
2Vital Voices Global Partnership501(c)(3)$12 millionWashington, DC
3Namati501(c)(3)$4.9 millionWashington, DC
4The One Campaign501(c)(3)$23 millionWashington, DC
5International Center for Journalists (ICFJ)501(c)(3)$17 millionWashington, DC
6Women for Women International501(c)(3)$21 millionWashington, DC
7Global Fund for Children501(c)(3)$8.3 millionWashington, DC
8Tostan501(c)(3)$6.0 millionWashington, DC
9Unitarian Universalist Service Committee (UUSC)501(c)(3)$8.7 millionCambridge, MA
10Population Action International (PAI)501(c)(3)$15 millionWashington, DC
11International Budget Partnership (IBP)501(c)(3)$19 millionWashington, DC
12Development Gateway501(c)(3)$8.9 millionWashington, DC
13Tanager501(c)(3)$6.6 millionWashington, DC
14International Initiative for Impact Evaluation (3ie)501(c)(3)$6.7 millionWashington, DC
15Results for Development (R4D)501(c)(3)$19 millionWashington, DC
16Radiant Earth501(c)(3)$2.8 millionWashington, DC
17African Center for Economic Transformation501(c)(3)$3.7 millionWashington, DC
18TrustAfrica501(c)(3)$3.1 millionWashington, DC
19Village Capital501(c)(3)$5.8 millionWashington, DC
20American International Health Alliance501(c)(3)$15 millionWashington, DC
21Invisible Children501(c)(3)$6.1 millionWashington, DC
22Priory in the USA of the Order of St John501(c)(3)$2.4 millionWashington, DC
23Global Genes501(c)(3)$4.9 millionAliso Viejo, CA
24Malaria No More Fund501(c)(3)$3.6 millionSeattle, WA
25Clinton Foundation501(c)(3)$30 millionLittle Rock, AR